ArticlePathogens (Basel, Switzerland)2022

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection.

Toni Herta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.